Catherine Roche

Marseille, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Unraveling the Genetic Heterogeneity of Isolated Growth Hormone Deficiency: Insights from the GENHYPOPIT Cohort.

Unraveling the Genetic Heterogeneity of Isolated Growth Hormone Deficiency: Insights from the GENHYPOPIT Cohort.

Journal: Hormone research in paediatrics

Published: February 09, 2026

Unravelling a KMT2A::ARHGEF12 fusion within chromoanagenesis in acute myeloid leukemia using Optical Genome Mapping.

Unravelling a KMT2A::ARHGEF12 fusion within chromoanagenesis in acute myeloid leukemia using Optical Genome Mapping.

Journal: Annals of hematology

Published: April 02, 2024

A Cohort Study of CNS Tumors in Multiple Endocrine Neoplasia Type 1.

A Cohort Study of CNS Tumors in Multiple Endocrine Neoplasia Type 1.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: October 26, 2023

Co-Targeting MAP Kinase and Pi3K-Akt-mTOR Pathways in Meningioma: Preclinical Study of Alpelisib and Trametinib.

Co-Targeting MAP Kinase and Pi3K-Akt-mTOR Pathways in Meningioma: Preclinical Study of Alpelisib and Trametinib.

Journal: Cancers

Published: July 27, 2022

Somatotroph Tumors and the Epigenetic Status of the GNAS Locus.

Somatotroph Tumors and the Epigenetic Status of the GNAS Locus.

Journal: International journal of molecular sciences

Published: June 03, 2021

Kinome rewiring during acquired drug resistance in neuroendocrine neoplasms.

Kinome rewiring during acquired drug resistance in neuroendocrine neoplasms.

Journal: Endocrine-related cancer

Published: September 29, 2020

Brief CommunicationCirculating tumor DNA is present in the most aggressive meningiomas.

Brief CommunicationCirculating tumor DNA is present in the most aggressive meningiomas.

Journal: Neuro-oncology advances

Published: July 10, 2020

Lethal toxicities after capecitabine intake in a previously 5-FU-treated patient: why dose matters with dihydropryimidine dehydrogenase deficiency.

Lethal toxicities after capecitabine intake in a previously 5-FU-treated patient: why dose matters with dihydropryimidine dehydrogenase deficiency.

Journal: Pharmacogenomics

Published: September 06, 2019

Everolimus and Octreotide for Patients with Recurrent Meningioma: Results from the Phase II CEVOREM Trial.

Everolimus and Octreotide for Patients with Recurrent Meningioma: Results from the Phase II CEVOREM Trial.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: July 03, 2019

Using Digital Droplet Polymerase Chain Reaction to Detect the Mosaic GNAS Mutations in Whole Blood DNA or Circulating Cell-Free DNA in Fibrous Dysplasia and McCune-Albright Syndrome.

Using Digital Droplet Polymerase Chain Reaction to Detect the Mosaic GNAS Mutations in Whole Blood DNA or Circulating Cell-Free DNA in Fibrous Dysplasia and McCune-Albright Syndrome.

Journal: The Journal of pediatrics

Published: June 04, 2018

CDA as a predictive marker for life-threatening toxicities in patients with AML treated with cytarabine.

CDA as a predictive marker for life-threatening toxicities in patients with AML treated with cytarabine.

Journal: Blood advances

Published: November 13, 2017

Anti-proliferative and anti-secretory effects of everolimus on human pancreatic neuroendocrine tumors primary cultures: is there any benefit from combination with somatostatin analogs?

Anti-proliferative and anti-secretory effects of everolimus on human pancreatic neuroendocrine tumors primary cultures: is there any benefit from combination with somatostatin analogs?

Journal: Oncotarget

Published: July 26, 2016

Showing 1-12 of 17

Last Updated: 09/26/2026